To mark World Cancer Day, we've highlighted some innovative strategies for cancer therapy developed in Israel.

ImmPACT Bio was formed from a merger with Israeli company Immpact, which was raised in the FutuRX biotech incubator, and US company Kalthera.

Alpha Tau signed an agreement with Nasdaq-listed SPAC Healthcare Capital Corp to continue delivering on its radiation cancer treatment.

Founded in 2016, Alpha Tau developed a breakthrough cancer treatment called Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy).

Oncohost developed a platform to identify key biological processes and proteins that drive response in patients undergoing cancer treatment.

The company developed breakthrough radiation cancer therapy and is embarking on a number of new of clinical trials.

To mark World Cancer Day, NoCamels is highlighting some recent findings in research, clinical trials, detection methods, and new therapies - all from so far this year.

Alpha Tau Medical's Alpha DaRT technology delivers high-precision alpha radiation that decays inside tumor, killing cancer cells while sparing surrounding healthy tissue.

The medical company, founded in 2016, has developed an innovative alpha radiation cancer therapy that it says can kill cancer cells.

One of the latest attempts to boost the body’s defenses against cancer is called adoptive cell transfer. But this therapy is extremely expensive and not always technically feasible. Israeli scientists have now tested in mice a new form of the therapy, which overcomes the limitations and enhances the tumor-fighting ability of the cells.